SPHAERA PHARMA PRIVATE LTD has a total of 47 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are KLAR ULRICH, MCCALL JOHN M and ORGANON NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | United States | 7 | |
#5 | Japan | 3 | |
#6 | Taiwan | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Steroids | |
#6 | Special acyclic compounds | |
#7 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Dugar Sundeep | 43 |
#2 | Mahajan Dinesh | 36 |
#3 | Patil Ishwar Rakesh | 13 |
#4 | Rai Kumar Santosh | 9 |
#5 | Sen Somdutta | 7 |
#6 | Schreiner Frederic George | 7 |
#7 | Rao Kanury | 5 |
#8 | Tripathi Vinayak | 5 |
#9 | Singh Varshneya | 5 |
#10 | Rai Santosh Kumar | 5 |
Publication | Filing date | Title |
---|---|---|
CN110312709A | Combined composition comprising epicatechin and anticancer compound | |
EP3472176A1 | Utility of (+) epicatechin and their analogs | |
EP3429992A1 | Trigonelline based compounds | |
WO2016013030A2 | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | |
CN106659697A | Novel compounds as anti-tubercular agents | |
EP2981260A2 | Novel analogues of epicatechin and related polyphenols | |
CN110003159A | Synthesize the new method of catechin | |
EP2948152A2 | Novel compounds of 11beta-hydroxy-steroids for use in mitochondria biogenesis and diseases associated with mitochondrial dysfunction or depletion | |
CN110526864A | New compound, its synthesis and application thereof | |
WO2012137225A1 | Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds | |
WO2012101654A2 | Novel triazine compounds | |
CN103582635A | A novel process for synthesis of polyphenols |